Core Insights - OneWater Marine reported Q3 FY2025 GAAP revenue of $552.9 million, exceeding analyst expectations and reflecting a 1.9% year-over-year increase [1][5] - Adjusted earnings per share (non-GAAP) were $0.79, significantly below the consensus estimate of $1.12 and down from $1.05 in Q3 FY2024, indicating margin pressures and lower profits [1][2] - The company demonstrated resilience in sales and market share gains despite broader industry weakness, outperforming the industry with a 2% increase in same-store sales compared to an industry decline of over 10% [1][5] Financial Performance - Revenue for Q3 FY2025 was $552.9 million, surpassing the estimate of $532.0 million, with a year-over-year increase from $542.4 million [2] - Adjusted EBITDA fell to $32.8 million, down 16.3% from $39.2 million in Q3 FY2024 [2] - Gross profit margin decreased to 23.3%, down 1.1 percentage points from the previous year, reflecting ongoing aggressive promotions and a shift in the mix of boats sold [2][7] Business Overview - OneWater Marine operates nearly 100 retail dealerships and multiple distribution centers across the U.S., focusing on the sale of new and pre-owned boats, marine parts, service, and insurance products [3] - The company partners with top boat manufacturers and targets premium and high-demand brands, enhancing its market position [3][4] Growth Strategy - The growth strategy includes expanding store footprint through acquisitions and diversifying revenue sources, with a focus on managing inventory levels and maintaining competitive pricing [4] - OneWater aims to streamline its product portfolio by exiting low-performing brands and focusing on higher-quality offerings, which is expected to improve margins in future quarters [9][11] Inventory and Cost Management - Inventory was reduced by 13.6% year-over-year to $517.1 million, indicating disciplined inventory management as part of a broader cleanup strategy [9] - Operating expenses increased to $92.1 million, or 16.7% of total revenue, driven by efforts to boost same-store sales and inflationary costs [10] Future Outlook - Management updated FY2025 guidance, projecting full-year revenue between $1.80 billion and $1.85 billion, with adjusted EBITDA forecasted at $65 million to $80 million [12] - Profitability expectations were lowered due to ongoing price competition and margin pressures, with adjusted diluted EPS now expected to fall between $0.50 and $0.75 [12]

Financial Data and Key Metrics Changes - Adjusted revenue for Q1 2025 was $751 million, down 8.5% year-over-year from $821 million in Q1 2024, primarily driven by the government segment [15][18] - Adjusted EBITDA for the quarter was $37 million, compared to $36 million in Q1 2024, with an adjusted EBITDA margin of 4.9%, up 50 basis points year-over-year [15][16] - New business annual contract value (ACV) increased by 14% year-over-year to $109 million, with total contract value (TCV) up 96% to $280 million [13][14] Business Line Data and Key Metrics Changes - Commercial segment adjusted revenue was $402 million, down 4.1% year-over-year, with adjusted EBITDA down 11% and EBITDA margin at 10%, down 70 basis points [16][17] - Government segment adjusted revenue decreased by 16% to $216 million, with adjusted EBITDA down 31% to $38 million and an EBITDA margin of 17.6% [17][18] - Transportation segment adjusted revenue was $133 million, down 7.6% year-over-year, but adjusted EBITDA improved to $6 million from $1 million in Q1 2024, with an EBITDA margin of 4.5% [19] Market Data and Key Metrics Changes - Qualified ACV pipeline increased by 16% year-over-year to $3.2 billion, with both government and commercial segments showing significant growth [14] - The company reported a strong sales pipeline and improved retention in the government business, indicating potential for future growth [29] Company Strategy and Development Direction - The company is focused on portfolio rationalization to enhance growth and reduce costs, having completed three divestitures in 2024 generating nearly $800 million in net proceeds [11][12] - The strategy includes targeting additional assets for divestiture expected to generate another $350 million in proceeds, surpassing the $1 billion target [11][12] - Investments in AI and fraud prevention capabilities are being emphasized, particularly in government services, to drive efficiency and reduce fraud [35][36] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about achieving revenue guidance despite macroeconomic uncertainties, citing minimal exposure to tariffs and a strong pipeline of government contracts [8][24] - The company expects Q2 2025 revenue to be sequentially higher than Q1 but slightly below Q2 2024, with adjusted EBITDA margin projected between 4% and 4.5% [26][27] - Management highlighted opportunities in government efficiency and fraud reduction as key growth areas, particularly in Medicaid and SNAP programs [30][34] Other Important Information - The company ended the quarter with approximately $293 million in cash and a largely undrawn $550 million revolving credit facility [21] - Adjusted free cash flow for the quarter was negative $74 million, an improvement compared to Q1 2024 [21] - The company incurred $3 million in expenses related to a cyber event, with $22 million accrued for potential notification requirements [20] Q&A Session Summary Question: How does the push for government efficiency create opportunities for the company? - Management explained that while federal funds for entitlements are distributed through states, the administrative costs present opportunities for the company to help states improve efficiency and reduce fraud [40][41][43] Question: Can you elaborate on the cyber event and its impact? - Management confirmed that all costs related to the cyber event are accounted for, with no significant operational impact, and ongoing examination of data is in progress [46][47] Question: Have there been any regulatory hurdles in deploying AI solutions? - Management stated that there have been no regulatory hurdles encountered in deploying AI, particularly in sensitive government applications [52][53] Question: What criteria are used for identifying assets for divestiture? - Management indicated that the focus is on identifying assets with scarcity value and maximizing returns from divestitures while balancing debt reduction and reinvestment [58][59] Question: What feedback is being received from state and local contacts regarding opportunities? - Management noted a mixed response from states, with some actively seeking to reduce fraud and improve efficiency, while others are more cautious [71][72]

Financial Data and Key Metrics Changes - Adjusted revenue for Q1 2025 was $751 million, down 8.5% year over year from $821 million in Q1 2024, primarily driven by the government segment [15][19] - Adjusted EBITDA for the quarter was $37 million, slightly up from $36 million in Q1 2024, with an adjusted EBITDA margin of 4.9%, an increase of 50 basis points year over year [15][19] - New business annual contract value (ACV) increased by 14% year over year to $109 million, with total contract value (TCV) up 96% to $280 million [13][14] Business Line Data and Key Metrics Changes - Commercial segment adjusted revenue was $402 million, down 4.1% year over year, with adjusted EBITDA down 11% and EBITDA margin at 10%, down 70 basis points [16][18] - Government segment adjusted revenue decreased by 16% to $216 million, with adjusted EBITDA down 31% to $38 million and an EBITDA margin of 17.6% [18][19] - Transportation segment adjusted revenue was $133 million, down 7.6% year over year, but adjusted EBITDA improved to $6 million from $1 million in Q1 2024, with an EBITDA margin of 4.5% [20] Market Data and Key Metrics Changes - Qualified ACV pipeline increased by 16% year over year to $3.2 billion, with both government and commercial segments showing significant growth [14] - The company reported a strong sales pipeline and improved retention in the government business, indicating a positive outlook for future growth [30] Company Strategy and Development Direction - The company is focused on portfolio rationalization, having completed three divestitures in 2024 that generated nearly $800 million in net proceeds, with plans for further asset sales in 2025 [11][12] - The strategy includes leveraging government opportunities, enhancing AI capabilities, and improving operational efficiencies to drive growth [30][38] - The company aims to reduce debt and increase profitability through capital deployment from divestitures, targeting an optimized portfolio with two operating units [11][12] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about achieving guidance numbers for 2025 despite macroeconomic uncertainties, citing minimal exposure to tariffs and a strong government business pipeline [7][24] - The company expects Q2 2025 revenue to be sequentially higher than Q1 but slightly below Q2 2024, with adjusted EBITDA margin projected between 4% and 4.5% [26] - Management highlighted opportunities in fraud reduction and government efficiency initiatives as key growth drivers [36][38] Other Important Information - The company ended the quarter with approximately $293 million in cash and a largely undrawn $550 million revolving credit facility [22] - Adjusted free cash flow for the quarter was negative $74 million, an improvement compared to Q1 2024 [22] - The company incurred $3 million in expenses related to a cyber event, with no material operational impact reported [21][49] Q&A Session Summary Question: Can you elaborate on how government efficiency efforts create opportunities for the company? - Management explained that while federal funds for entitlements are distributed through states, the administrative costs present opportunities for the company to help states improve efficiency and reduce fraud [41][45] Question: What was the impact of the cyber event? - Management confirmed that all costs related to the cyber event are accounted for, with no significant operational impact, and ongoing examination of data is in progress [48][49] Question: Have there been any regulatory hurdles in deploying AI solutions? - Management stated that there have been no regulatory hurdles encountered in deploying AI, particularly in sensitive government or healthcare applications [54][55] Question: What criteria are used for identifying assets for divestiture? - Management indicated that the focus is on identifying assets with scarcity value and maximizing returns from divestitures while balancing debt reduction and reinvestment [60][62] Question: What feedback is being received from state and local contacts regarding opportunities? - Management noted a mixed response from states, with some actively seeking efficiency improvements while others are more cautious, but overall, there is a strong interest in fraud reduction initiatives [73][75]

Financial Data and Key Metrics Changes - The company reported a net income attributable to Universal Health Services per diluted share of $4.96 for Q4 2024, with an adjusted net income of $4.92 per diluted share [6] - Adjusted admissions to acute care hospitals increased by 2.2% year-over-year, while same facility net revenues in the acute care segment rose by 8.7%, driven by a 5.3% increase in net revenue per adjusted admission [6] - Cash generated from operating activities was $658 million in Q4 2024, compared to $452 million in Q4 2023, and $2.067 billion for the full year 2024, up from $1.268 billion in 2023 [9] Business Line Data and Key Metrics Changes - Same facility revenues at behavioral health hospitals increased by 11.1%, primarily due to an 8.7% increase in revenue per adjusted patient day [8] - The company recorded $50 million in net incremental reimbursements from various state supplemental Medicaid programs during Q4 2024, exceeding prior projections [9] - Operating expenses were well managed, with premium pay declining to $60 million in Q4 2024, consistent with the previous two quarters [7] Market Data and Key Metrics Changes - The company anticipates a slight decrease in total consolidated Medicaid supplemental payments for 2025 compared to 2024 [13] - The demand for behavioral services remains solid, with a forecasted growth in same facility adjusted patient days of 2.5% to 3% for 2025 [14] Company Strategy and Development Direction - The company is focused on expanding its outpatient presence and broadening its continuum of care, with plans to open new facilities and enhance technology investments in behavioral hospitals [10][14] - The company aims to maintain a leverage level in the high twos, approaching three, while using free cash flow primarily for share repurchases [61][62] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about a more stable operating environment in 2025, with expectations of mid-single-digit EBITDA growth [13][20] - The current political environment presents uncertainty regarding Medicaid reimbursement, but management believes there is significant political support for Medicaid programs at the state level [15][49] Other Important Information - The company spent $944 million on capital expenditures in 2024, consistent with forecasts, and has plans for new hospital openings in 2025 [10][11] - As of December 31, 2024, the company had $1.17 billion of available borrowing capacity under its revolving credit facility [12] Q&A Session Summary Question: What is driving the higher underlying growth in 2025 despite state supplemental payments forecasted to be down year over year? - Management indicated that core EBITDA growth is driven by solid volume growth, robust pricing, and effective expense control, with a more stable operating environment expected [20] Question: Why is the guidance range for 2025 wider than usual? - Management acknowledged that items beyond their control, such as government reimbursement changes, contribute to the wider range in guidance [24] Question: What is the main reason for the decline in DPP payments? - The decline is primarily due to recognizing DPP payments related to prior periods in 2024, rather than significant changes in specific programs [29] Question: How adequate are the malpractice reserves? - Management stated that they have moved towards the higher end of the range for reserves, hoping to avoid further adjustments in 2025 [32] Question: What are the assumptions for acute revenue growth in 2025? - Management expects mid-single-digit revenue growth in the acute division, split evenly between price and volume [73] Question: How does the company view the impact of the flu season on Q1? - Management noted that while the flu season has been strong, it typically does not have a significant impact on earnings [131] Question: What is the expected impact of new hospital openings on consolidated revenue and EBITDA? - New hospitals are expected to be EBITDA positive, but may cause some cannibalization of existing business, affecting same-store metrics [120]